)
Andrew Peterson
Director,
Akiiwan Therapeutics
Peterson has a PhD in Genetics from Harvard University and post-doctoral experience at UCSF. He has more than 30 years of research and development experience, including faculty appointments at Duke University and at UCSF. Dr Peterson joined Genentech in 2005 and directed the Department of Molecular Biology, providing support for discovery research. He also led discovery efforts in metabolic disease that advanced programs into development and Phase 2 trials. Dr. Peterson was CSO of MedGenome, a research services and molecular diagnostics company, where he developed a genotyping platform optimized for Asian populations. Dr Peterson is founder and CEO of Broadwing Bio, an ocular disease focused Biotech.